Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Free Radic Biol Med ; 168: 6-15, 2021 05 20.
Article in English | MEDLINE | ID: mdl-33781892

ABSTRACT

Autism spectrum disorders (ASDs) are highly associated with oxidative stress. We have recently shown that Disconnected-interacting protein homolog 2 A (DIP2A) functions in ASD pathophysiology by regulating cortactin acetylation for spine development and synaptic transmission. However, its role is not fully understood in the context of its abundant expression in mitochondria. In this paper, we found that DIP2A was involved in superoxide dismutase (SOD)-mediated antioxidative reactions. In mice, DIP2A knockout inhibited SOD activity and increased reactive oxygen species (ROS) levels in the cerebral cortex. In vitro gain-of-function experiments further confirmed the positive role of DIP2A in scavenging ROS upon oxidative stress. Moreover, DIP2A knockout caused irregular mitochondrial morphology in the cerebral cortex and impaired mitochondrial metabolism with an over consumption of lipids for energy supply. Taken together, these results revealed unrecognized functions of DIP2A in antioxidative protection, providing another possible explanation for DIP2A-mediated ASD pathophysiology.


Subject(s)
Antioxidants , Staphylococcal Protein A , Animals , Brain/metabolism , Mice , Nuclear Proteins/metabolism , Oxidative Stress , Reactive Oxygen Species , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism
2.
Cell Biosci ; 10: 98, 2020.
Article in English | MEDLINE | ID: mdl-32843960

ABSTRACT

BACKGROUND: Schwann cells (SCs) play a crucial role in Wallerian degeneration after peripheral nerve injury. The expression of genes in SCs undergo a series of changes, which greatly affect the proliferation and apoptosis of SCs as well as the fate of peripheral nerve regeneration. However, how do these genes regulate the proliferation and apoptosis of SCs remains unclear. RESULTS: SPP1 and PKCα were found upregulated after human median peripheral nerve injury, which promoted SCs proliferation and survival. The promoted proliferation and inhibited apoptosis by SPP1 were blocked after the treatment of PKCα antagonist Gö6976. Whereas, the inhibited proliferation and enhanced apoptosis induced by silence of SPP1 could be rescued by the activation of PKCα, which suggested that SPP1 functioned through PKCα. Moreover, both CD44 and αvß3 were found expressed in SCs and increased after peripheral nerve injury. Silence of CD44 or ß3 alleviated the increased proliferation and inhibited apoptosis induced by recombinant osteopontin, suggesting the function of SPP1 on SCs were dependent on CD44 and ß3. CONCLUSION: These results suggested that SPP1 promoted proliferation and inhibited apoptosis of SCs through PKCα signaling pathway by binding with CD44 and αvß3. This study provides a potential therapeutic target for improving peripheral nerve recovery.

3.
J Cell Mol Med ; 23(2): 1622-1627, 2019 02.
Article in English | MEDLINE | ID: mdl-30484953

ABSTRACT

Disabled-1 (Dab1) is best known as an adaptor protein regulating neuron migration and lamination during development. However, the exact function of Dab1 in breast cancer is unknown. In this study, we examined the expression of Dab1 in 38 breast cancer paraffin sections, as well as 60 paired frozen breast cancer and their adjacent tissues. Our results showed that Dab1 was reduced in breast cancer, and its compromised expression correlated with triple negative breast cancer phenotype, poor differentiation, as well as lymph node metastasis. Functional analysis in breast cancer cell lines demonstrated that Dab1 promoted cell apoptosis, which, at least partially, depended on its regulation of NF-κB/Bcl-2/caspase-9 pathway. Our study strongly suggests that Dab1 may be a potential tumour suppressor gene in breast cancer.


Subject(s)
Adaptor Proteins, Signal Transducing/genetics , Breast Neoplasms/genetics , Nerve Tissue Proteins/genetics , Triple Negative Breast Neoplasms/genetics , Adult , Aged , Aged, 80 and over , Apoptosis/genetics , Breast Neoplasms/pathology , Caspase 9/genetics , Disease-Free Survival , Female , Gene Expression Regulation, Neoplastic/genetics , Humans , MCF-7 Cells , Middle Aged , NF-kappa B/genetics , Prognosis , Proto-Oncogene Proteins c-bcl-2/genetics , Transcription Factor RelA/genetics , Triple Negative Breast Neoplasms/pathology , bcl-2-Associated X Protein/genetics
4.
Behav Neurol ; 2017: 2941297, 2017.
Article in English | MEDLINE | ID: mdl-28928602

ABSTRACT

BACKGROUND: Long noncoding RNAs were involved in the processes of diabetes. Our study was aimed to explore clinical potential of LncRNA NONRATT021972 in diabetic neuropathic pain and investigate detailed mechanisms. METHODS: 154 patients with type 2 diabetes were enrolled as experimental group paired with control. Patients without diabetes but neuropathy were enrolled to explore exclusive role of LncRNA NONRATT021972 in neuropathy. Real-time PCR and ELISA were performed to examine expression of LncRNA and TNF-α in flood. Neuropathic pain scores were calculated with data from NPQ. Streptozotocin was used for SD adult male rats to establish diabetes for NONRATT021972 siRNA or saline treatment. Neuropathic pain behaviors and expression of TNF-α were assessed. RESULT: Patients with type 2 diabetes had a significantly higher concentration of LncRNA NONRATT021972 in blood and more severe symptoms of neuropathic pain. LncRNA NONRATT021972 was positively associated with neuropathic pain scores of type 2 diabetes. TNF-α level increased in patients with type 2 diabetes. Animal experiment showed that LncRNA NONRATT021972 siRNA attenuated inflammation via decreasing TNF-α and alleviated neuropathic pain. CONCLUSION: LncRNA NONRATT021972 increased in type 2 diabetes and was positively associated with neuropathic pain scoring in type 2 diabetes. LncRNA NONRATT021972 exacerbated neuropathic pain via TNF-α related pathways.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/metabolism , Diabetic Neuropathies/diagnosis , Neuralgia/diagnosis , RNA, Long Noncoding/metabolism , Aged , Animals , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Type 2/genetics , Diabetic Neuropathies/genetics , Diabetic Neuropathies/metabolism , Diabetic Neuropathies/therapy , Female , Humans , Male , Middle Aged , Neuralgia/genetics , Neuralgia/metabolism , Neuralgia/therapy , Pain Measurement , RNA, Long Noncoding/genetics , RNA, Small Interfering , Rats , Rats, Sprague-Dawley , Severity of Illness Index , Tumor Necrosis Factor-alpha/metabolism
5.
J Mol Neurosci ; 56(4): 917-925, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25877688

ABSTRACT

In the present study, the effects of erythropoietin (EPO) on preventing adult neurons from apoptosis (introduced by brachial plexus avulsion) were examined, and the mechanism was analyzed. Fifty injury rat models were established in this study by using micro-hemostat forceps to pull out brachial plexus root from the intervertebral foramen in supine position. These models were divided into EPO group (avulsion + 1000 U/kg subcutaneously on alternate days) and control group (avulsion + normal saline). C5-T1 spinal cord was harvested at days 1, 2, 4, 7, and 14. Compared with the control group, the apoptosis of spinal motoneurons was significantly decreased on days 4 and 7 in the EPO group, which was also approved by TUNEL examination results. The detection of p-JNK and expression of c-Jun and cleavage of cleaved PARP (c-PARP) were also examined by immunohistochemistry and were increased immediately at day 1, and peaked at day 2, day 2, and day 4 in control group, respectively. However, the amounts were decreased and delayed by EPO treatment significantly at the same time points. In conclusion, the apoptosis of adult spinal motorneurons was associated with JNK phosphorylation, c-Jun expression, and caspase activity, and EPO-mediated neuronal protective effect is proved by downregulating the JNK phosphorylation and c-Jun expression and inhibiting of c-PARP cleavage.


Subject(s)
Apoptosis , Brachial Plexus/metabolism , Erythropoietin/pharmacology , MAP Kinase Signaling System , Neurons/metabolism , Peripheral Nerve Injuries/metabolism , Animals , Brachial Plexus/cytology , Brachial Plexus/growth & development , Brachial Plexus/injuries , Down-Regulation , Erythropoietin/therapeutic use , JNK Mitogen-Activated Protein Kinases/metabolism , MAP Kinase Kinase 4/genetics , MAP Kinase Kinase 4/metabolism , Male , Neurons/drug effects , Peripheral Nerve Injuries/drug therapy , Poly(ADP-ribose) Polymerases/metabolism , Proteolysis , Rats , Rats, Wistar
6.
Cereb Cortex ; 24(5): 1259-68, 2014 May.
Article in English | MEDLINE | ID: mdl-23300110

ABSTRACT

During embryonic development of the mammalian cerebral cortex, postmitotic cortical neurons migrate radially from the ventricular zone to the cortical plate. Proper migration involves the correct orientation of migrating neurons and the transition from a multipolar to a mature bipolar morphology. Herein, we report that the 2 isoforms of Myosin-10 (Myo10) play distinct roles in the regulation of radial migration in the mouse cortex. We show that the full-length Myo10 (fMyo10) isoform is located in deeper layers of the cortex and is involved in establishing proper migration orientation. We also demonstrate that fMyo10-dependent orientation of radial migration is mediated at least in part by the netrin-1 receptor deleted in colorectal cancer. Moreover, we show that the headless Myo10 (hMyo10) isoform is required for the transition from multipolar to bipolar morphologies in the intermediate zone. Our study reveals divergent functions for the 2 Myo10 isoforms in controlling both the direction of migration and neuronal morphogenesis during radial cortical neuronal migration.


Subject(s)
Cell Movement/genetics , Cerebral Cortex/cytology , Cerebral Cortex/embryology , Myosins/metabolism , Neurons/physiology , Analysis of Variance , Animals , Cells, Cultured , DCC Receptor , Electroporation , Embryo, Mammalian , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , In Vitro Techniques , Ki-67 Antigen/metabolism , Mice, Inbred C57BL , Mice, Transgenic , Microtubule-Associated Proteins/metabolism , Myosins/genetics , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurogenesis , Protein Isoforms/genetics , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Tubulin/metabolism , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...